NDC 76204-010-05 - Albuterol Sulfate Inhalation Solution
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76204-010
- Requested NDC
- 76204-010-05
- Package NDCs from labels
- 76204-010-11, 76204-010-01, 76204-010-05, 76204-010-55
- Manufacturer
- Ritedose Pharmaceuticals, LLC
- Effective date
- 2026-04-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Albuterol Sulfate Inhalation Solution - Ritedose Pharmaceuticals, LLC | Ritedose Pharmaceuticals, LLC | 2026-04-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Albuterol Sulfate Inhalation Solution - RedPharm Drug | RedPharm Drug | 2024-07-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76204-010-01 | Albuterol Sulfate Inhalation Solution | 30 in 1 CARTON | SOLUTION | 30 | 10 | |
| 76204-010-05 | Albuterol Sulfate Inhalation Solution | 3 mL in 1 VIAL | SOLUTION | 3 | 10 | |
| 76204-010-05 | Albuterol Sulfate Inhalation Solution | 5 in 1 POUCH | SOLUTION | 5 | 10 | |
| 76204-010-11 | Albuterol Sulfate Inhalation Solution | 3 mL in 1 VIAL | SOLUTION | 3 | 10 | |
| 76204-010-11 | Albuterol Sulfate Inhalation Solution | 1 in 1 POUCH | SOLUTION | 1 | 10 | |
| 76204-010-55 | Albuterol Sulfate Inhalation Solution | 25 in 1 CARTON | SOLUTION | 25 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 76204-010-01 | ML - Milliliter | 76204-010 | 4e27cde8-f221-4666-8c2d-508a892b675a | 1 | 2022-04-06 |
| 76204-010-05 | ML - Milliliter | 76204-010 | 20e2d491-ea43-486f-a60b-6d55e2a29de9 | 1 | 2022-04-06 |
| 76204-010-11 | ML - Milliliter | 76204-010 | 9587c64c-b59b-464c-b827-8ae0734da554 | 1 | 2022-04-06 |
| 76204-010-55 | ML - Milliliter | 76204-010 | 089313ec-b5d2-4af0-82a2-c973c9d44202 | 1 | 2022-04-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | af5cdf1a-19f4-11e2-892e-0800200c9a66 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 19daf830-7270-4661-81b1-ded38f867f28 | 2026-07-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Whisidom Saline Solution | SODIUM CHLORIDE 0.9% SALINE SOLUTION | Jiangxi Yudexi Pharmaceutical Co., LTD | 4e4e4169-2a14-3466-e063-6394a90a081b | 2026-07-20 | Warnings | 451W47IQ8X |
| Saline | NASAL | BEST CHOICE (VALU MERCHANDISERS COMPANY) | 71485e82-bf54-4b8b-8dd2-2a0761534520 | 2026-07-17 | Warnings | 451W47IQ8X |
| Albuterol Sulfate | ALBUTEROL SULFATE | Rising Pharma Holdings, Inc. | 3236f82c-14e9-dfd4-e063-6294a90ac43d | 2026-07-16 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Rising Pharma Holdings, Inc. | 3246dfab-61d7-27ba-e063-6294a90ac180 | 2026-07-16 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Rising Pharma Holdings, Inc. | 32377c09-da6d-331c-e063-6294a90a7a46 | 2026-07-16 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Rising Pharma Holdings, Inc | 32474c0e-af35-69d1-e063-6394a90a53c6 | 2026-07-16 | Warnings, Adverse reactions | 351137 351136 021SEF3731 |
| WHWSWB 0.9% SALINE | SODIUM CHLORIDE | Yiwu Huanshu E-commerce Co., Ltd | 5082b773-79b2-2501-e063-6394a90a170f | 2026-07-11 | Warnings | 451W47IQ8X |
| SALINE NASAL | SODIUM CHLORIDE | ALAINA HEALTHCARE PRIVATE LIMITED | ed30a7f9-7132-42da-9bed-63a9b1c80ab2 | 2026-07-07 | Warnings | 451W47IQ8X |
| Albuterol Sulfate | ALBUTEROL SULFATE | HAWAII REPACK, INC. | b18fad6e-f117-4840-83b7-8c261c646af1 | 2026-07-03 | Warnings, Adverse reactions | 021SEF3731 |
| The Cell Salt Co. Daily Blend 12 in 1 | CALC FLUOR, CALC PHOS, CALC SULPH, FERRUM PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT MUR, NAT PHOS, NAT SULPH, SILICEA | The Cell Salt Company LLC | 55826f59-acf4-7370-e063-6394a90afed7 | 2026-07-01 | Warnings | 451W47IQ8X |
| NebuClear MD Saline | NEBUCLEAR MD SALINE | Blue Echo Care LLC | 55820ff9-7b4b-2bce-e063-6394a90a8b43 | 2026-06-30 | Warnings | 451W47IQ8X |
| NebuClear MD Saline | NEBUCLEAR MD SALINE | Blue Echo Care LLC | 55806cb8-cf92-c4e5-e063-6394a90aaa2d | 2026-06-30 | Warnings | 451W47IQ8X |
| NebuClear MD Saline | NEBUCLEAR MD SALINE | Blue Echo Care LLC | 5581d8e5-4105-e9da-e063-6394a90a316e | 2026-06-30 | Warnings | 451W47IQ8X |
| Albuterol Sulfate | ALBUTEROL SULFATE | American Health Packaging | 4aec7f59-b429-4b0e-a779-8df1dd8f80d7 | 2026-06-23 | Warnings, Adverse reactions | 021SEF3731 |
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Cipla USA Inc. | 3c64255e-074c-41f8-a344-3686a0685020 | 2026-06-22 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | REMEDYREPACK INC. | 0f9bf2c8-55c0-4b4d-97de-d6c7220c3862 | 2026-06-17 | Warnings, Adverse reactions | 021SEF3731 |
| 0.9% Sodium Chloride Saline Solution | SODIUM CHLORIDE | Yunqi Cosmetics (Shenzhen) Co., Ltd | 546af257-dbd1-11fc-e063-6394a90a8e0a | 2026-06-16 | Warnings | 451W47IQ8X |
| BM BM68 DROPS | ARGENTUM NIT, BARYTA CARB., DULCAMARA, GELSEMIUM, KALI BROM, NAT MUR, CAUSTICUM | BM Private Limited | 53f9c99a-0f20-0358-e063-6394a90af4e0 | 2026-06-15 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.